These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 21078154)

  • 1. Genetics of SCID.
    Cossu F
    Ital J Pediatr; 2010 Nov; 36():76. PubMed ID: 21078154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term outcomes of severe combined immunodeficiency: therapy implications.
    Heimall J; Cowan MJ
    Expert Rev Clin Immunol; 2017 Nov; 13(11):1029-1040. PubMed ID: 28918671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe combined immunodeficiency (SCID): from molecular basis to clinical management.
    Sponzilli I; Notarangelo LD
    Acta Biomed; 2011 Apr; 82(1):5-13. PubMed ID: 22069950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically-determined defects of T cell development.
    Notarangelo LD
    Allergy Asthma Proc; 2024 Sep; 45(5):326-331. PubMed ID: 39294907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy for severe combined immunodeficiency.
    Cavazzana-Calvo M; Lagresle C; Hacein-Bey-Abina S; Fischer A
    Annu Rev Med; 2005; 56():585-602. PubMed ID: 15660528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The case for mandatory newborn screening for severe combined immunodeficiency (SCID).
    Gaspar HB; Hammarström L; Mahlaoui N; Borte M; Borte S
    J Clin Immunol; 2014 May; 34(4):393-7. PubMed ID: 24691999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How I treat severe combined immunodeficiency.
    Gaspar HB; Qasim W; Davies EG; Rao K; Amrolia PJ; Veys P
    Blood; 2013 Nov; 122(23):3749-58. PubMed ID: 24113871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Criteria and Evaluation of Severe Combined Immunodeficiency in the Neonate.
    Diamond CE; Sanchez MJ; LaBelle JL
    Pediatr Ann; 2015 Jul; 44(7):e181-7. PubMed ID: 26171708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in genes required for T-cell development: IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review.
    Kalman L; Lindegren ML; Kobrynski L; Vogt R; Hannon H; Howard JT; Buckley R
    Genet Med; 2004; 6(1):16-26. PubMed ID: 14726805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multisystem Anomalies in Severe Combined Immunodeficiency with Mutant BCL11B.
    Punwani D; Zhang Y; Yu J; Cowan MJ; Rana S; Kwan A; Adhikari AN; Lizama CO; Mendelsohn BA; Fahl SP; Chellappan A; Srinivasan R; Brenner SE; Wiest DL; Puck JM
    N Engl J Med; 2016 Dec; 375(22):2165-2176. PubMed ID: 27959755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADA Deficiency: Evaluation of the Clinical and Laboratory Features and the Outcome.
    Cagdas D; Gur Cetinkaya P; Karaatmaca B; Esenboga S; Tan C; Yılmaz T; Gümüş E; Barış S; Kuşkonmaz B; Ozgur TT; Bali P; Santisteban I; Orhan D; Yüce A; Cetinkaya D; Boztug K; Hershfield M; Sanal O; Tezcan İ
    J Clin Immunol; 2018 May; 38(4):484-493. PubMed ID: 29744787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Wisconsin approach to newborn screening for severe combined immunodeficiency.
    Verbsky J; Thakar M; Routes J
    J Allergy Clin Immunol; 2012 Mar; 129(3):622-7. PubMed ID: 22244594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Severe combined immunodeficiency: From its discovery to the perspective].
    Kanegane H; Imai K; Morio T
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(3):145-154. PubMed ID: 28747600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Laboratory Factors Affecting the Prognosis of Severe Combined Immunodeficiency.
    Ozturk E; Catak MC; Kiykim A; Baser D; Bilgic Eltan S; Yalcin K; Kasap N; Nain E; Bulutoglu A; Akgun G; Can Y; Sefer AP; Babayeva R; Caki-Kilic S; Tezcan Karasu G; Yesilipek A; Ozen A; Karakoc-Aydiner E; Baris S
    J Clin Immunol; 2022 Jul; 42(5):1036-1050. PubMed ID: 35451701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe combined immunodeficiency diagnosis and genetic defects.
    Aranda CS; Gouveia-Pereira MP; da Silva CJM; Rizzo MCFV; Ishizuka E; de Oliveira EB; Condino-Neto A
    Immunol Rev; 2024 Mar; 322(1):138-147. PubMed ID: 38287514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe combined immunodeficiency in Serbia and Montenegro between years 1986 and 2010: a single-center experience.
    Pasic S; Vujic D; Veljković D; Slavkovic B; Mostarica-Stojkovic M; Minic P; Minic A; Ristic G; Giliani S; Villa A; Sobacchi C; Lilić D; Abinun M
    J Clin Immunol; 2014 Apr; 34(3):304-8. PubMed ID: 24481607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous resolution of severe idiopathic T cell lymphopenia.
    Habiballah SB; Whangbo JS; Cardona ID; Platt CD
    Clin Immunol; 2022 May; 238():109014. PubMed ID: 35447312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes.
    Buckley RH
    Immunol Res; 2011 Apr; 49(1-3):25-43. PubMed ID: 21116871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and genetic profiles of 44 patients with severe combined immunodeficiency (SCID): report from Shanghai, China (2004-2011).
    Yao CM; Han XH; Zhang YD; Zhang H; Jin YY; Cao RM; Wang X; Liu QH; Zhao W; Chen TX
    J Clin Immunol; 2013 Apr; 33(3):526-39. PubMed ID: 23250629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newborn Screening for SCID and Other Severe Primary Immunodeficiency in the Polish-German Transborder Area: Experience From the First 14 Months of Collaboration.
    Giżewska M; Durda K; Winter T; Ostrowska I; Ołtarzewski M; Klein J; Blankenstein O; Romanowska H; Krzywińska-Zdeb E; Patalan MF; Bartkowiak E; Szczerba N; Seiberling S; Birkenfeld B; Nauck M; von Bernuth H; Meisel C; Bernatowska EA; Walczak M; Pac M
    Front Immunol; 2020; 11():1948. PubMed ID: 33178177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.